Home › Funds › Biondo Investment Advisors, LLC › KRYS

Biondo Investment Advisors, LLC position in KRYS

KRYSTAL BIOTECH INC · Health Care

Biondo Investment Advisors, LLC reported holding 71,233 shares of KRYS (KRYSTAL BIOTECH INC) in its Q3 2026 13F filing — a position valued at US$23.7M, representing 2.82% of its reported portfolio and ranking #8 among its reported holdings. Biondo Investment Advisors, LLC has disclosed KRYS holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)71.23K sh
Reported value held$23.69M
Portfolio Weight2.82%
First reportedQ2 2025
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Biondo Investment Advisors, LLC's KRYS position evolved

Biondo Investment Advisors, LLC first disclosed a stake in KRYS in Q2 2025 at 21,240 shares (US$2.9M). The position peaked in Q2 2026 at 70,945 shares, worth US$26.4M. Across 6 filings, Biondo Investment Advisors, LLC increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 71,233 shares valued at US$23.7M. Notable position changes include a 144% increase in Q3 2025 (shares rose 40% over the following quarter), a 31% increase in Q4 2025 (shares rose 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 21.24K $2.92M New
Q3 2025 51.88K $9.16M Add
Q4 2025 68.13K $16.80M Add
Q1 2026 72.05K $18.61M Add
Q2 2026 70.94K $26.37M Reduce
Q3 2026 71.23K $23.69M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KRYS and 13F data

KRYS (KRYSTAL BIOTECH INC) is a Health Care company. 42 other funds we track also report a position in KRYS — the largest reported positions include Avoro Capital Advisors LLC (US$1.07B), Soleus Capital Management, L.P. (US$349.1M), Hood River Capital Management LLC (US$246.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KRYS

All KRYS fund holders →

FAQ

How long has Biondo Investment Advisors, LLC held KRYS?

Biondo Investment Advisors, LLC has disclosed KRYS holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is Biondo Investment Advisors, LLC's current position in KRYS?

As of Q3 2026, Biondo Investment Advisors, LLC holds 71.23K shares of KRYS (KRYSTAL BIOTECH INC), valued at $23.69M, representing 2.82% of its reported portfolio and ranking #8.

Has Biondo Investment Advisors, LLC been buying or selling KRYS?

In the latest 13F filing (Q3 2026), Biondo Investment Advisors, LLC held unchanged its position in KRYS. The position peaked in Q2 2026 at 70.94K shares.

Which other funds hold KRYS?

Other major institutional holders of KRYS include Avoro Capital Advisors LLC, Soleus Capital Management, L.P., Hood River Capital Management LLC, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.